Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction.
By Gregg Stone, C. Grines, D. Cox, Eulogio J. García, J. Tcheng, John J. Griffin, G. Guagliumi, T. Stuckey, M. Turco, J. Carroll and 2 more. New England Journal of Medicine, 2002
1,316 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Surgery
View Paper: https://www.semanticscholar.org/paper/b0674c719132a403501ab5136f4283710756d1b8
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
In Surgery
Citations in the corpus
- Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. (2003, background): “In the largest study, the CADILLAC trial, a favourable effect of abciximab was only observed when abciximab was given during primary angioplasty but not during primary stenting.(89)”